浅析上海市医疗机构自行研制使用体外诊断试剂的监管模式A Brief Analysis of the Regulatory Model for In-House Development and Use of In Vitro Diagnostic Reagents by Medical Institutions in Shanghai
王安婷,梁爽
摘要(Abstract):
2022年底,我国开始实施医疗机构自行研制使用体外诊断试剂试点工作。该文通过对比美国实验室自建检测方法监管路径的演变、欧盟体外诊断医疗器械法规对“内部使用”器械的监管要求与我国试点政策的异同,系统梳理了上海市“国家遴选品种+省级备案+联动监管”的实践模式,并针对试点中暴露的技术评估标准难以统一、临床证据不足、主体责任落实难等问题,提出构建分层分类评价体系、探索真实世界数据应用、强化全生命周期监管等优化建议,以期为全国自制试剂监管制度的完善提供参考。
关键词(KeyWords): 医疗机构;自行研制;体外诊断试剂;监管模式;上海实践
基金项目(Foundation):
作者(Author): 王安婷,梁爽
参考文献(References):
- [1]国家药品监督管理局.对十三届全国人大三次会议第8110号建议的答复[EB/OL].(2020-11-19)[2025-10-21]. https://www.nmpa.gov.cn/directory/web/nmpa/zwgk/jyta/rdjy/20201119153604133.html.
- [2]中华人民共和国国务院.医疗器械监督管理条例[EB/OL].(2024-12-06)[2025-10-20]. https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art_70607fc4160041a383e68ff6bfb2826f.html.
- [3]韩昭昭,赵阳,吕允凤,等.浅析美国实验室研发试剂监管模式[J].中国医疗器械杂志,2022,46(5):534-537.
- [4]U. S. Food and Drug Administration. FDA and CMS:Americans deserve accurate and reliable diagnostic tests,wherever they are made[EB/OL].(2024-01-18)[2025-11-23]. https://www.fda.gov/medical-devices/medical-devicesnews-and-events/fda-and-cms-americans-deserve-accurateand-reliable-diagnostic-tests-wherever-they-are-made.
- [5]周良彬,汤智,张春青,等.美国食品药品监督管理局最新实验室开发试剂(LDT)监管政策的思路探究及启示[J].中国医疗器械信息,2024,30(13):1-7,22.
- [6]Bennett S A,Conn C M,Gill H E,et al. Regulatory requirements for laboratory developed tests in the United States[J]. J Immunol Methods,2025,537:113813.
- [7]U. S. Food and Drug Administration. Medical Devices;Laboratory Developed Tests[EB/OL].(2024-06-25)[2025-12-26]. https://www.federalregister.gov/documents/2024/05/06/2024-08935/medical-devices-laboratory-developedtests.
- [8]U. S. Food and Drug Administration. Laboratory Developed Tests[EB/OL].(2025-09-19)[2025-12-26].https://www.fda.gov/medical-devices/in-vitro-diagnostics/laboratory-developed-tests.
- [9]Kahles A, Volckmar AL, Goldschmid H, et al.Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union—a comparative overview[J]. ESMO Open,2025,10(12):105909.
- [10]周良彬,祁瑞娟,黄颖.欧盟关于医疗机构内部器械指南及其监管思路探讨[J].中国医疗器械信息,2023,29(3):4-6,34.
- [11]上海市医疗器械检验研究院.医械院助力首个医疗机构自行研制使用体外诊断试剂完成备案[EB/OL].(2024-08-09)[2026-01-25]. https://yjj.sh.gov.cn/yl-tpxw/20241211/61795a2fc350466f95b7be8ed59a74cd.html.
- [12]何婷,白茹,谢能.浅谈医疗机构自行研制体外诊断试剂质量管理体系的通用要求[J].中国医疗器械杂志,2025,49(2):219-223.